logo
Select company
Select metric
Ticker Information

Ticker

MGX

Company Name

METAGENOMI INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

METAGENOMI INC - Capital Expenditures to Operating Cash Flow Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MGX - CapEx/OCF Historical data
DateCapital ExpenditureCapital Expenditures to Operating Cash FlowNet Cash Flow - Operations
6/30/2025$ 1.91M0%$ -97.01M
3/31/2025$ 2.49M0%$ -102.06M
12/31/2024$ 3.11M0%$ -109.07M
9/30/2024$ 4.52M0%$ -103.39M
12/31/2023$ 9.81M0%$ -91.41M
12/31/2022$ 13.98M47.02%$ 29.72M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • METAGENOMI INC's latest trailing twelve months (TTM) CapEx/OCF stands at 47.02%.
  • Over the past 5 years, METAGENOMI INC's average CapEx/OCF has been 47.02%.
  • The median CapEx/OCF for METAGENOMI INC during this period was 47.02%
  • METAGENOMI INC reached its highest CapEx/OCF over the past 5 years at 47.02%.
  • The lowest CapEx/OCF recorded by METAGENOMI INC in the same timeframe 47.02%

METAGENOMI INC's CapEx/OCF vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CapEx/OCF Benchmarks
CompanyCapEx/OCF
ICCC : IMMUCELL CORP 29.2%WHWK : WHITEHAWK THERAPEUTICS INC -MRSN : MERSANA THERAPEUTICS INC -IRD : OPUS GENETICS INC -VRCA : VERRICA PHARMACEUTICALS INC -HYFT : MINDWALK HOLDINGS CORP -EQ : EQUILLIUM INC -BRNS : BARINTHUS BIOTHERAPEUTICS PLC -DOMH : DOMINARI HOLDINGS INC -IVVD : INVIVYD INC -

Definition of Capital Expenditures to Operating Cash Flow

[Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
CapEx / CF - Operations
(=) CapEx/OCF
CapEx/OCF for METAGENOMI INC is calculated as follows: CapEx [ $ 13.98M ] / CF - Operations [ $ 29.72M ]
(=) CapEx/OCF [ 47.02% ]

MGX - Capital Expenditures to Operating Cash Flow, Last 5 years

47.02%

Minimum

Dec 31, 2022

47.02%

Maximum

Dec 31, 2022

47.02%

Average

47.02%

Median

CapEx/OCF Benchmark Analysis

The chart above depicts the distribution of CapEx/OCF for companies in the Total Stock Market. The average CapEx/OCF of the companies is 31.82% with a standard deviation of 29.52%.
The following table provides additional summary stats:
CapEx/OCF in the Market:
filtered constituents2.35K
min0.01%
max128%
average31.82%
median22.42%
std29.52%